Miltenyi Biomedicine
cancer and regenerative therapies
- B2B
About Miltenyi Biomedicine
Development of innovative cell and gene therapies focusing on cancer treatments and regenerative medicine for patients with unmet needs.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Bergisch Gladbach, North Rhine-Westphalia, Germany
- Founded
- 2019
- Revenue
- $23.7M – $187MTamtam estimate
- Website
- miltenyibiomedicine.com
Miltenyi Biomedicine at a glance
Miltenyi Biomedicine is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany.
Miltenyi Biomedicine was founded in 2019.
Miltenyi Biomedicine has 51–250 employees.
Miltenyi Biomedicine's revenue is $23.7M – $187M (Tamtam estimate).
Frequently asked questions about Miltenyi Biomedicine
What is Miltenyi Biomedicine's revenue?
Tamtam estimates Miltenyi Biomedicine's annual revenue at $23.7M – $187M.
How many employees does Miltenyi Biomedicine have?
Miltenyi Biomedicine has 51–250 employees.
Where is Miltenyi Biomedicine headquartered?
Miltenyi Biomedicine is headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany.
Selling to companies like Miltenyi Biomedicine?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies